Cardiac pacing: how it started, where we are, where we are going.
about
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyNew horizon for infection prevention technology and implantable deviceManagement of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality.The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival.
P2860
Cardiac pacing: how it started, where we are, where we are going.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cardiac pacing: how it started, where we are, where we are going.
@ast
Cardiac pacing: how it started, where we are, where we are going.
@en
type
label
Cardiac pacing: how it started, where we are, where we are going.
@ast
Cardiac pacing: how it started, where we are, where we are going.
@en
prefLabel
Cardiac pacing: how it started, where we are, where we are going.
@ast
Cardiac pacing: how it started, where we are, where we are going.
@en
P2860
P1476
Cardiac pacing: how it started, where we are, where we are going.
@en
P2093
David L Hayes
Seymour Furman
P2860
P304
P356
10.1111/J.1540-8159.2004.00515.X
P577
2004-05-01T00:00:00Z